for the purpose of alleviating pulmonary hypertension and maintaining cardiac output , which tended to be decreased to acute low-flow oxygen therapy in chronic lung diseases , we evaluated combined low-flow oxygen therapy and oral administration of op-1206 , a prostaglandin e1 derivative , in 7 patients with obstructive lung disease and 3 with restrictive one .
C0020542
pulmonary hypertension
C0002335
prostaglandin e1